Blood tests for Alzheimer’s disease are now so accurate that a positive result, on its own, is reason enough for people who are suspected of having AD to start immunotherapy. So proffered Suzanne ...

The therapeutic antibody lecanemab has been in clinical use in the U.S. for two years, and doubts about whether it would be feasible for clinics to implement and manage this therapy have eased. Even ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected] ...